RS Crum Inc’s AbbVie ABBV Stock Holding History

RS Crum Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$558K	Hold	2,217	–	–	0.1%	60
2026 Q1	$482K	Hold	2,217	–	–	0.09%	61
2025 Q4	$507K	Sell	2,217 -100	-4%	-$22.8K	0.1%	58
2025 Q3	$536K	Hold	2,317	–	–	0.12%	53
2025 Q2	$430K	Hold	2,317	–	–	0.1%	60
2025 Q1	$485K	Buy	2,317 +37	+2%	+$7.19K	0.13%	54
2024 Q4	$405K	Buy	2,280 +100	+5%	+$18.4K	0.1%	62
2024 Q3	$431K	Sell	2,180 -1	-0%	-$187	0.1%	62
2024 Q2	$374K	Buy	2,181 +480	+28%	+$79.5K	0.1%	65
2024 Q1	$310K	Sell	1,701 -116	-6%	-$20K	0.08%	68
2023 Q4	$282K	Sell	1,817 -33	-2%	-$4.81K	0.09%	69
2023 Q3	$276K	Buy	1,850 +250	+16%	+$36.7K	0.1%	65
2023 Q2	$216K	Hold	1,600	–	–	0.08%	70
2023 Q1	$255K	Hold	1,600	–	–	0.1%	67
2022 Q4	$259K	Hold	1,600	–	–	0.12%	66
2022 Q3	$215K	Sell	1,600 -1,603	-50%	-$230K	0.11%	67
2022 Q2	$491K	Hold	3,203	–	–	0.25%	45
2022 Q1	$519K	Hold	3,203	–	–	0.29%	42
2021 Q4	$434K	Buy	+3,203	New	+$378K	0.24%	47

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RS Crum Inc's ABBV Position: Q2 2026 in Review

RS Crum Inc held its AbbVie (ABBV) position steady in Q2 2026 at 2,217 shares worth $558K. The position accounts for 0.1% of the portfolio, ranked #60.

RS Crum Inc first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

RS Crum Inc held 2,217 shares of AbbVie worth $558K as of Q2 2026.
RS Crum Inc left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.1% of RS Crum Inc's portfolio in Q2 2026, its #60 holding.
RS Crum Inc first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on RS Crum Inc's 13F filing for Q2 2026, filed 10 Aug 2026.